RE: 2022.7 Feb 2022 13:47
@Straycat
You and I both realise the value of 2022 if $85 Brent and an average 50k bopd is achieved. I would just counter on a couple of points:
- I think it erroneous to label investment capex as a cash release. Quite the opposite, it is a cash injection into the business. Yes, it could be funded by internally generated cash flow this year but it consumes a big chunk of that 2022 free cash flow rather than releasing it
- the phrase cash cow would normally be reserved for companies producing a lot of free cash flow from ordinary operations. With GKP the situation is somewhat different. We have an off-balance sheet asset called the CRP. It was paid for, in large part, by pre-2016 shareholders and it was one of the assets purchased at great discount by those who participated in the restructuring and those who have and are buying shares post that point until now. 78% of monthly receipts are the monetisation of this asset, the balance of which is being reduced swiftly. It has been topped up by monthly capex and direct operating and G&A expenses and reduced by circa 78% of monthly receipts. 2022 will likely be a big year for bringing this balance down towards zero (or rather to the level of expenses incurred in the billing cycle). Thereafter company free cash flow plummets. So at best you could say it is a "2022 cash cow."
- while we may not need KRG approval to invest ahead of their deliberations one would be very foolish to invest $200m without the FDP. I expect a burn focused solely on maintenance and SH13/14/15 until we have clarity on the FDP and can begin investing, firstly, in additional processing capacity.
- as we both know, when a company pays out cash it is worth commensurately less as a result. So our focus should continue to be on those events which help generate additional cash rather than events which disburse it. Progress on 13/14/15 and other production metrics, the price of oil (both short term and expectations for medium and long term), FDP and any renegotiation (if any) of the PSC etc.
I think you've begun to get a handle on cash receipts for 2022. I would suggest you take that model a little further and work out your expected free cash flow generation for the year subtracting opex, direct G&A, capex, finance costs, corporate overhead. Then of course subtract your assumed dividend/buyback disbursements from this free cash flow plus existing net cash. Also have a crack at estimating the CRP as of end 2022. Then do the above for 2023 with the impact of a far lower CRP balance in mind (and recognising there's also a debt payment due that year). From that number you can make a call on how much the company can disburse per annum post 2022.
Addendum: I just saw your last post. I don't think it is lost at all on the KRG as to who pays for the bulk of investment capex. They know they do.